The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness of immune checkpoint inhibitors alone or in combination with chemotherapy in metastatic non–small cell lung cancer.
 
Lingzhi Hong
No Relationships to Disclose
 
Waree Rinsurongkawong
No Relationships to Disclose
 
Maliazurina B Saad
No Relationships to Disclose
 
Pingjun Chen
No Relationships to Disclose
 
Muhammad Aminu
No Relationships to Disclose
 
Amy R. Spelman
No Relationships to Disclose
 
Marcelo Vailati Negrao
Consulting or Advisory Role - Merck; Mirati Therapeutics
Research Funding - Alaunos Therapeutics; AstraZeneca; Checkmate Pharmaceuticals; Genentech; Mirati Therapeutics; Novartis; Pfizer; ZIOPHARM Oncology
Other Relationship - Apothecom; Ashfield Healthcare; ZIOPHARM Oncology
 
Tina Cascone
Honoraria - Bristol-Myers Squibb; Brystol-Myers Squibb; Medscape; Roche; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Arrowhead Pharmaceuticals; AstraZeneca; Bristol Myers Squibb; EMD Serono; Genentech; MedImmune; Merck
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Parker Institute for Cancer Immunotherapy
 
Steven H. Lin
Employment - MD Anderson Cancer Center
Stock and Other Ownership Interests - Scenexo
Honoraria - AstraZeneca/MedImmune; BeyondSpring Pharmaceuticals
Consulting or Advisory Role - Scenexo
Speakers' Bureau - AstraZeneca
Research Funding - BeyondSpring Pharmaceuticals; Nektar; STCube Pharmaceuticals Inc.
Travel, Accommodations, Expenses - Elekta; STCube Pharmaceuticals Inc.
 
Percy Lee
Employment - MD Anderson Cancer Center
Leadership - The Radiosurgery Society
Honoraria - AstraZeneca/MedImmune; Genentech/Roche; Varian Medical Systems; ViewRay
Consulting or Advisory Role - Genentech/Roche; Varian Medical Systems; ViewRay
Speakers' Bureau - AstraZeneca/MedImmune
Research Funding - AstraZeneca/MedImmune; AstraZeneca/MedImmune
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Varian Medical Systems; ViewRay; ViewRay
 
Boris Sepesi
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex
Speakers' Bureau - AstraZeneca
 
Jeff Lewis
No Relationships to Disclose
 
Don Lynn Gibbons
Stock and Other Ownership Interests - Exact Sciences; Nektar
Consulting or Advisory Role - GlaxoSmithKline; Janssen Research & Development; Lilly; Menarini; Mitobridge; Napa Therapeutics; Ribon Therapeutics; Sanofi
Research Funding - AstraZeneca; Boehringer Ingelheim (Inst); Janssen Research & Development; Mirati Therapeutics (Inst); Mitobridge; NGM Biopharmaceuticals; Ribon Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BerGenBio; Takeda
 
Ara A. Vaporciyan
No Relationships to Disclose
 
J. Jack Lee
Honoraria - AstraZeneca; AstraZeneca
 
Xiuning Le
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; EMD Serono; Lilly; Spectrum Pharmaceuticals
Research Funding - Boehringer Ingelheim (Inst); Lilly (Inst)
 
Jia Wu
No Relationships to Disclose
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; BrightPath Biotheraputics; Bristol-Myers Squibb; Catalyst Biotech; EMD Serono; Foundation medicine; Genentech/Roche; GlaxoSmithKline; Guardant Health; Hengrui Pharmaceutical; Janssen; Kairos Ventures; Leads Biolabs; Lilly; Mirati Therapeutics; Nexus Health Systems; Novartis; Pneuma Respiratory; Roche; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda
Research Funding - AstraZeneca (Inst); GlaxoSmithKline; Spectrum Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations
 
Jianjun Zhang
Honoraria - CancerNet; Geneplus; Geneplus; innovent biologics; Innovent Biologics; Innovent Biologics; Origimed; Roche; Sino-USA Biomedical Platform; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Capital Medical University; Geneplus; Johnson & Johnson/Janssen; Novartis
Research Funding - Merck; Novartis
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital
 
Natalie I Vokes
Honoraria - Sanofi
Consulting or Advisory Role - Sanofi/Regeneron